Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals

Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals 4th March 2021

Mawdsleys is delighted to now be partnering with Morningside Pharmaceuticals as an additional distributor to supply their contract and non-contract products to hospitals.

Morningside has a portfolio of 242 generic and branded licensed medicines in the UK and EU and is a proud manufacturer and supplier to NHS Trusts, pharmacy chains, pharmaceutical wholesalers, as well as clinics and dispensing doctors in the UK.

Morningside’s products are available for customers to order now from Mawdsleys.

Other latest news

We’re progressing our sustainability commitments

We are currently trialling an electric trailer refrigeration unit. The E-Cool Trailer is an all-electric, engineless, refrigeration system that converts the kinetic energy generated by the trailer axel and brakes into electricity, which is then stored in a battery pack that powers the onboard refrigeration unit that’s required for the…

Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer. Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…